أرسل هذا في رسالة قصيرة: Detection and dynamic changes of EGFR mutations from circulating tumor DNA as a predictor of survival outcomes in NSCLC Patients treated with first-line intercalated erlotinib and chemotherapy

 ______    _    _    ______    __   __    ______  
|      \\ | || | || |      \\  \ \\/ //  /_   _// 
|  --  // | || | || |  --  //   \ ` //   `-| |,-  
|  --  \\ | \\_/ || |  --  \\    | ||      | ||   
|______//  \____//  |______//    |_||      |_||   
`------`    `---`   `------`     `-`'      `-`'